Angioedema with renin angiotensin system drugs and neutral endopeptidase inhibitors

Journal of the American Society of Hypertension

Volumn 10, Issue 5, 2016, Pages 387-389

  Kostis, John B ^a   Moreyra, Abel E ^a   Kostis, William J ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL; ENKEPHALINASE INHIBITOR; OMAPATRILAT; SACUBITRIL; SACUBITRIL PLUS VALSARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MEMBRANE METALLOENDOPEPTIDASE; PROTEINASE; PROTEINASE INHIBITOR; RENIN;

ANGIONEUROTIC EDEMA; COUGHING; FOLLOW UP; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOTENSION; INCIDENCE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; DRUG EFFECT;

ANGIOEDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ENDOPEPTIDASES; HUMANS; HYPERTENSION; NEPRILYSIN; PROTEASE INHIBITORS; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 84962548205     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2016.02.017     Document Type: Editorial

References (15)

1. J.J.V. McMurray, M. Packer, A.S. Desai, et al. for the PARADIGM-HF Investigators and Committees Angiotensin-neprilysin inhibition versus enalapril in heart failure N Engl J Med 371 2014 993 1004
2. M.R. Shah, and M.S. Lauer Striking the right balance in heart failure Ann Intern Med 164 2016 125 126
3. H. Gavras A multicenter trial of enalapril in the treatment of essential hypertension Clin Ther 9 1 1986 24 38
4. J.I. Drayer, and M.A. Weber Monotherapy of essential hypertension with a converting-enzyme inhibitor Hypertension 5 1983 III108 III113
5. J.B. Kostis Angiotensin-converting enzyme-inhibitors - emerging differences and new compounds Am J Hypertens 2 1 1989 57 64
6. W. Vleeming, J.G. van Amsterdam, B.H. Stricker, and D.J. de Wildt ACE inhibitor-induced angioedema: incidence, prevention and management Drug Saf 18 1998 171 188
7. E.E. Slater, D.D. Merrill, H.A. Guess, and et al. Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition JAMA 260 1988 967 970
8. Z.H. Israili, and W.D. Hall Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy: a review of the literature and pathophysiology Ann Intern Med 17 1992 234 242
9. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
10. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions N Engl J Med 327 1992 685 691
11. J.B. Kostis, M. Packer, H.R. Black, R. Schmieder, D. Henry, E. Levy, and et al. Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial Am J Hypertens 17 2004 103 111
12. Kostis JB, Wilson AC. Incidence of angioedema in SOLVD. JACC 39(5):Suppl A:166A, 2002. Presented at the 51st Annual Sci Sessions of the Am Coll of Cardiol in Atlanta, GA.
13. J.B. Kostis, H.J. Kim, J. Rusnak, T. Casale, A. Kaplan, J. Corren, and et al. Incidence and characteristics of angioedema associated with enalapril Arch Intern Med 165 2005 1637 1642
14. G.A. Burkhart Angiotensin converting enzyme inhibitor-associated angioedema: higher risk in blacks than whites Pharmacoepidemiol Drug Saf 5 1996 149 154
15. N.J. Brown, W.A. Ray, M. Snowden, and M.R. Griffin Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema Clin Pharmacol Ther 60 1996 8 13